EAACI Position Papers and EAACI Task Force Reports

Fungal exposome, human health and unmet needs: a 2022 update with special focus on allergy

Vitte, J., Michel, M., Malinovschi, A., et al. Allergy. First published: 17 August 2022

---

Diagnosis and management of allergy and respiratory disorders in sport: An eaaci task force position paper

Price, O.J., Walsted, E.S., Bonini, M., et al. Allergy. First published: 09 July 2022

---

Role of dietary fiber in promoting immune health – An EAACI position paper

Venter, C., Meyer, R.W., Greenhawt, M., et al. Allergy. First published: 08 July 2022

---

Omics technologies in allergy and asthma research: an EAACI position paper

Radzikowska, U., Baerenfaller, K., Cornejo-Garcia, J.A., et al. Allergy. First published: 17 June 2022

---

Allergic and hypersensitivity conditions in non-specialist care: Flow diagrams to support clinical practice

Ryan, D, Flokstra – de Blok, BMJ, Clark, E, et al. Allergy. First published: 10 March 2022

---

Effects of non-steroidal anti-inflammatory drugs and other eicosanoid pathway modifiers on antiviral and allergic responses. EAACI task force on eicosanoids consensus report in times of COVID-19

Sokolowska, M., Rovati, G., Diamant, Z., et al. Allergy. First published: 16 February 2022

---

AllergoOncology: Danger signals in allergology and oncology. A European Academy of Allergy and Clinical Immunology (EAACI) Position Paper

Bergmann, C., Poli, A., Agache, I., et al. Allergy. First published: 13 February 2022

---

COVID-19 vaccination in patients receiving allergen immunotherapy (AIT) or biologicals – EAACI recommendations

Jutel, M., Torres, M.J., Palomares, O., et al. Allergy. First published: 11 February 2022

---

Allergies and COVID-19 vaccines: An ENDA/EAACI Position paper

Barbaud, A., Garvey, L.H., Arcolaci, A., et al. Allergy. First published: 02 February 2022

---

Alpine Altitude Climate Treatment for severe and uncontrolled asthma: an EAACI Position Paper

Fieten, K., Drijver-Messelink, M., Cogo, A., et al. Allergy. First published: 03 February 2022

---

The international WAO/EAACI guideline for the management of hereditary angioedema – the 2021 revision and update

Maurer, M., Magerl, M., Betschel, S., et al. Allergy. First published: 10 January 2022

---

EAACI position paper on the clinical use of the bronchial allergen challenge: unmet needs and research priorities

Agache, I., Antolin-Amerigo, D., de Blay, F., et al. Allergy. First published: 02 January 2022

---

Proposal of 0.5 mg of protein/100 g of processed food as threshold for voluntary declaration of food allergen traces in processed food—A first step in an initiative to better inform patients and avoid fatal allergic reactions: A GA²LEN position paper

Zuberbier, T, Dörr, T, Aberer, W, et al. Allergy. First published: 06 November 2021

---

Hypersensitivity reactions to chemotherapy: An EAACI position paper

Pagani, M., Bavbek, S., Alvarez-Cuesta, E., et al. Allergy. First published: 29 September 2021

---

Perceptions of adolescents and young adults with allergy and/or asthma and their parents on EAACI guideline recommendations about transitional care: A European survey.

Khaleva, E., Knibb, R., DunnGalvin, A., et al. Allergy. First published: 26 September 2021

---

Current allergy educational needs in primary care. Results of the EAACI working group on primary care survey exploring the confidence to manage and the opportunity to refer patients with allergy

Cabrera, M, Ryan, D, Angier, E, et al. Allergy. First published: 09 September 2021

---

One Health: EAACI position paper on coronaviruses at the human-animal interface, with a specific focus on comparative and zoonotic aspects of SARS-Cov-2

Korath, ADJ, Janda, J, Untersmayr, E, et al. Allergy.First published: 28 June 2021

---

Hypersensitivity reactions to biologicals: An EAACI position paper

Bavbek, S., Pagani, M., Alvarez-Cuesta, E., et al. Allergy.First published: 22 June 2021

---

Technical standards in allergen exposure chambers worldwide – an EAACI task force report

Pfaar, O., Bergmann, K., Bonini, S., et al. Allergy. First published: 24 May 2021

---

Adherence to the strengthening the reporting of observational studies in epidemiology (STROBE) checklist in articles published in EAACI journals: A bibliographic study

Wiehn, E., Ricci, C., Alvarez-Perea, A., et al. Allergy. First published: 22 May 2021

---

Dangerous liaisons: Bacteria, antimicrobial therapies, and allergic diseases

Tramper-Stranders, G, Ambrożej, D, Arcolaci, A, et al. Allergy. 2021; 76: 3276– 3291

---

Health effects of exposure to chlorination by-products in swimming pools

Couto, M, Bernard, A, Delgado, L, et al. Allergy. 2021; 76: 3257– 3275

---

Management of anaphylaxis due to COVID-19 vaccines in the elderly

Bousquet, J., Agache, I., Blain, H., et al. Allergy. 2021; 76: 2952-2964

---

Allergen immunotherapy: the growing role of observational and randomisedtrial “Real-World Evidence”

Paoletti, G., DiBona, D., Chu, D.K., et al. Allergy. 2021; 76: 2663-2672

---

Differentiation of COVID-19 signs and symptoms from allergic rhinitis and common cold: An ARIA-EAACI-GA2LEN consensus

Hagemann, J., Onorato, G.L., Jutel, M., et al. Allergy. 2021; 76: 2354-2366

---

EAACI statement on the diagnosis, management and prevention of severe allergic reactions to COVID-19 vaccines

Sokolowska, M., Eiwegger, T., Ollert, M., et al. Allergy. 2021; 76: 1629-1639

---

ARIA-EAACI statement on severe allergic reactions to COVID-19 vaccines – an EAACI-ARIA position paper

Klimek, L., Jutel, M., Akdis, C.A., Allergy. 2021; 76: 1624-1628

---

Practice parameters for diagnosing and managing iodinated contrast media hypersensitivity

Torres, MJ, Trautmann, A, Böhm, I, et al. Allergy. 2021; 76: 1325– 1339

---

Noninvasive and minimally invasive techniques for the diagnosis and management of allergic diseases

Baumann, R, Untersmayr, E, Zissler, UM, et al.Allergy. 2021; 76: 1010– 1023

---

ARIA-EAACI statement on asthma and COVID-19 (June 2, 2020)

Bousquet, J., Jutel, M., Akdis, C.A., et al. Allergy. 2021; 76: 689-697

---

Management of patients with chronic rhinosinusitis during the COVID-19 pandemic—An EAACI position paper

Klimek, L, Jutel, M, Bousquet, J, et al. Allergy. 2021; 76: 677– 688

---

COVID-19 pandemic: Practical considerations on the organization of an allergy clinic—An EAACI/ARIA position paper

Pfaar, O, Klimek, L, Jutel, M, et al. Allergy. 2021; 76: 648– 676

---

Placebo effects in allergen immunotherapy – an EAACI task force position paper

Pfaar, O, Agache, I, Bergmann, KC, et al. Allergy. 2021; 76: 629– 647

---

Current perspective on eicosanoids in asthma and allergic diseases: EAACI task force consensus report, part I

Sokolowska, M, Rovati, GE, Diamant, Z, et al. Allergy. 2021; 76: 114– 130

---

Immune modulation via T regulatory cell enhancement: Disease-modifying therapies for autoimmunity and their potential for chronic allergic and inflammatory diseases—An EAACI position paper of the task force on immunopharmacology (TIPCO)

Roth-Walter, F, Adcock, IM, Benito-Villalvilla, C, et al. Allergy. 2021; 76: 90– 113

---

Biologicals in atopic disease in pregnancy: An EAACI position paper

Pfaller, B, José Yepes-Nuñez, J, Agache, I, et al. Allergy. 2021; 76: 71– 89

---

The development of birch pollen seasons over 30 years in Munich, Germany—An EAACI task force report

Bergmann, K.-C., Buters, J., Karatzas, K., et al. Allergy. 2020; 75: 3024-3026

---

Diagnosis and management of the drug hypersensitivity reactions in coronavirus disease 19: An EAACI position paper

Gelincik, A, Brockow, K, Çelik, GE, et al. Allergy. 2020; 75: 2775– 2793

---

Considerations on biologicals for patients with allergic disease in times of the COVID-19 pandemic: An EAACI statement

Vultaggio, A, Agache, I, Akdis, CA, et al. Allergy. 2020; 75: 2764– 2774

---

Gender and occupational allergy: Report from the task force of the EAACI Environmental and Occupational Allergy Interest Group

Moscato, G, Apfelbacher, C, Brockow, K, et al. Allergy. 2020; 75: 2753– 2763

---

Immunology of COVID-19: Mechanisms, clinical outcome, diagnostics, and perspectives—A report of the European Academy of Allergy and Clinical Immunology (EAACI)

Sokolowska, M, Lukasik, ZM, Agache, I, et al. Allergy. 2020; 75: 2445– 2476

---

Intranasal corticosteroids in allergic rhinitis in COVID-19 infected patients: An ARIA-EAACI statement

Bousquet, J., Akdis, C.A., Jutel, M. Allergy, 75: 2440-2444

---

The effectiveness of interventions to improve self-management for adolescents and young adults with allergic conditions: A systematic review

Knibb, RC, Alviani, C, Garriga-Baraut, T, et al. Allergy. 2020; 75: 1881– 1898

---

Understanding the challenges faced by adolescents and young adults with allergic conditions: A systematic review

Vazquez-Ortiz, M, Angier, E, Blumchen, K, et al. Allergy. 2020; 75: 1850– 1880

---

Handling of allergen immunotherapy in the COVID-19 pandemic: An ARIA-EAACI statement

Klimek, L, Jutel, M, Akdis, C, et al. Allergy. 2020; 75: 1546– 1554

---

Towards a more precise diagnosis of hypersensitivity to beta-lactams - an EAACI position paper

Romano, A, Atanaskovic-Markovic, M, Barbaud, A, et al. Allergy. 2020; 75: 1300– 1315

---

Genetic variants associated with T cell-mediated cutaneous adverse drug reactions: A PRISMA-compliant systematic review-An EAACI position paper

Oussalah, A, Yip, V, Mayorga, C, et al. Allergy. 2020; 75: 1069– 1098

---

State-of-the-art in marketed adjuvants and formulations in Allergen Immunotherapy: A position paper of the European Academy of Allergy and Clinical Immunology (EAACI)

Jensen-Jarolim, E, Bachmann, MF, Bonini, S, et al. Allergy. 2020; 75: 746– 760

---

EAACI position paper on diet diversity in pregnancy, infancy and childhood: Novel concepts and implications for studies in allergy and asthma

Venter, C, Greenhawt, M, Meyer, RW, et al. Allergy. 2020; 75: 497– 523

---

The role of mobile health technologies in allergy care: An EAACI position paper

Matricardi, P, Dramburg, S, Alvarez-Perea, A, et al. Allergy. 2020; 75: 259– 272

---

Diagnosis and management of Non-IgE gastrointestinal allergies in breastfed infants-An EAACI Position Paper

Meyer, R, Chebar Lozinsky, A, Fleischer, DM, et al. Allergy. 2020; 75: 14– 32

---

Prioritizing research challenges and funding for allergy and asthma and the need for translational research—The European Strategic Forum on Allergic Diseases

Agache, I, Annesi-Maesano, I, Bonertz, A, et al. Allergy. 2019; 74: 2064– 2076

---

An EAACI position paper on the investigation of perioperative immediate hypersensitivity reactions

Garvey, LH, Ebo, DG, Mertes, P-M, et al. Allergy. 2019; 74: 1872– 1884

---

Food processing and occupational respiratory allergy- An EAACI position paper

Jeebhay, MF, Moscato, G, Bang, BE, et al. Allergy. 2019; 74: 1852– 1871

---

Toward clinically applicable biomarkers for asthma: An EAACI position paper

Diamant, Z, Vijverberg, S, Alving, K, et al. 2019; 74: 1835- 1851

---

Management of ocular allergy.

Leonardi, A, Silva, D, Perez Formigo, D, et al. Allergy. 2019; 74: 1611– 1630

---

EAACI position paper: Influence of dietary fatty acids on asthma, food allergy, and atopic dermatitis

Venter, C, Meyer, RW, Nwaru, BI, et al. Allergy. 2019; 74: 1429– 1444

---

A EAACI drug allergy interest group survey on how European allergy specialists deal with beta-lactam allergy

Torres, MJ, Celik, GE, Whitaker, P, et al. Torres, MJ, Celik, GE, Whitaker, P, et al. Allergy. 2019; 74: 1052– 1062

---

EAACI position paper: Comparing insect hypersensitivity induced by bite, sting, inhalation or ingestion in human beings and animals

Pali-Schöll, I, Blank, S, Verhoeckx, K, et al. Allergy. 2019; 74: 874– 887

---